Therapeutical treatments
AssigneeLaboratoires Goemar S.A.
InventorsJean-Claude Yvin, Vaclav Vetvicka
Life of this patent
Estimating the term…
Abstract
Therapeutical method comprising administration to a patient of an effective amount of especially soluble laminarin for the treatment of tumors and more generally of cancers of the group comprising breast cancer, lung cancer, oesophagus cancer, stomach cancer, intestine and colon cancers, and for the treatment of viral, bacterial and fungal diseases as well as diseases related to immunostimulant deficiencies of human beings and warm-blood animals.
Claims11
A therapeutical method comprising intravenous, intraperitoneal or oral administration of an amount of laminarin, comprised within a composition comprising laminarin and a pharmaceutically acceptable carrier, to a human or to a warm-blooded animal suffering from a tumor, a cancer, a viral disease, a bacterial disease, a fungal disease, a disease of the immune system, an auto-immune disease or a disease related to a deficiency of immunostimulation, in the human or the animal, wherein the amount of laminarin or the concentration of laminarin in the composition is effective to treat the tumor, the cancer or the disease.
The method of claim wherein the administration comprises intraperitoneal administration of an amount of laminarin of from about 0.1 mg/kg per day to about 50 mg/kg per day during a period from 5 to 15 days.
Dependencies are inferred from the claim text.